Learn, Empower, Understand
Video
Become your best advocate. Knowledge is power, take charge of your path.
Become your best advocate. Knowledge is power, take charge of your path.
Dr. Ed Kim from the Levine Cancer Institute reviews the potential advantages and current limitations of blood-based testing for molecular markers using circulating tumor cells and circulating tumor DNA in identifying clinically important mutations.
Dr. Ed Kim from the Levine Cancer Institute in Charlotte, NC summarizes the mechanism of next generation sequencing (NGS), how it can potentially be used, and its limitations in clinical practice today.
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock